Senseonics appoints Sharon Larkin to Board of Directors

Senseonics Holdings, Inc.

Appointed Sharon Larkin to the Board effective December 8, 2021, as a Class I director term expiring at 2023 annual meeting.
Ms. Larkin is a former senior VP of Assertio Therapeutics and previously divisional VP at Abbott's Medical Devices Group.
Received a restricted stock unit grant of 72,115 shares vesting in three equal annual installments, subject to continued service.
Appointed to the Compensation Committee and eligible for annual retainer of $40,000 as director plus $6,500 for committee service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sharon Larkin

director

SENS · Senseonics Holdings, Inc.

Effective: 2021-12-08
Filed: December 9, 2021, 6:59 PM ET

On December 8, 2021, the board of directors (the “Board”) of Senseonics Holdings, Inc. (the “Company”) appointed Sharon Larkin to serve as a director of the Company, which appointment became effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Sharon Larkin was appointed as director at Senseonics Holdings, Inc..

Action: appointed
Role: director

Exact text from the filing

On December 8, 2021, the board of directors (the “Board”) of Senseonics Holdings, Inc. (the “Company”) appointed Sharon Larkin to serve as a director of the Company, which appointment became effective immediately.

View on SEC.gov

Senseonics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-148194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.